Regional differences in the prostanoid receptors mediating prostaglandin F-induced contractions of cat isolated arteries

https://doi.org/10.1016/0014-2999(90)94169-XGet rights and content

Abstract

U46619, a stable thromboxane A2 (TXA2) mimetic, and prostaglandin F (PGF2a) contracted helical strips of cat coronary, renal and mesenteric arteries in a concentration-dependent manner. The EC50 values for U46619 did not differ significantly in these arteries, but those for PGF were in the order of coronary < renal < mesenteric arteries. Contractions induced by U46619 were antagonized by S-145, a selective TXA; receptor antagonist, with similar activity in these arteries. On the other hand, contractions induced by low concentrations of PGF(10−9 to 10−7 M) were not influenced by treatment with S-145 in coronary arteries, although those induced by high concentrations (5 × 10−7 to 10−5 M) were partially attenuated. These contractions resistant to the TXA2 antagonist were antagonized by diphloretin phosphate (DPP), a non-selective PG antagonist. Contractions induced by PGF(5 × 10−7 to 5 × 10−5 M) in mesenteric arteries were inhibited by S-145 in a concentration-dependent manner. Contractions induced by PGF in renal arteries were partially inhibited by S-145. The inhibitory activity of S-145 to PGF-induced contractions at EC50 was in the order of coronary < renal < mesenteric arteries. Treatment with indomethacin slightly potentiated the contractions induced by PGF in mesenteric arteries. Removal of the endothelium did not affect the contractile responses induced by PGF and the inhibitory activity of S-145 in the arteries. These results suggest that the contractile responses induced by low concentrations of PGF (up to 10−7 M) are associated with their action via PG receptor(s), which is different from TXA2 receptor, and those induced by high concentrations of PGF(5 × 10−7 M or higher) interact with TXA; receptors in cat vascular smooth muscles. It appears that the functional expression of this PG receptor(s) is greater in coronary arteries than in renal arteries, and that it is not found in mesenteric arteries.

References (38)

  • A. Ahluwalia et al.

    Prostanoid receptors mediating contraction of rabbit renal artery

    Br. J. Pharmacol.

    (1988)
  • H.J. Berger et al.

    Regional cardiac prostaglandin release during myocardial ischemia in anesthetized dogs

    Circ. Res.

    (1976)
  • R.M. Burch et al.

    Solubilization of a thromboxane A2/prostaglandin H2 antagonist binding site from human platelets

  • R.A. Coleman et al.

    Comparison of the actions of U46619, a prostaglandin H2 analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations

    Br. J. Pharmacol.

    (1981)
  • E.F. Ellis et al.

    Cerebral arterial smooth muscle contraction by thromboxane A2

    Stroke

    (1977)
  • R.F. Furchgott

    Role of endothelium in responses of vascular smooth muscle

    Circ. Res.

    (1983)
  • J.H. Gaddum et al.

    Quantitative studies of antagonists for 5-hydroxytryptamine

    Q.J. Exp. Physiol.

    (1955)
  • J. Hanasaki et al.

    Characterization of platelet thromboxane A2/prostaglandin H2 receptor by a novel thromboxane receptor antagonist, [3H]S-145

    Biochem. Pharmacol.

    (1989)
  • C. Ingerman-Wojenski et al.

    Bovine endothelial cells in culture produce thromboxane as well as prostacyclin

    J. Clin. Invest.

    (1981)
  • Cited by (0)

    View full text